These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31727111)

  • 21. Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians.
    Al-Samkari H
    Semin Thromb Hemost; 2022 Jul; 48(5):514-528. PubMed ID: 35226946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab as Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Literature Review.
    Kini SD; Yiu DW; Weisberg RA; Davila JF; Chelius DC
    Ann Otol Rhinol Laryngol; 2019 May; 128(5):467-471. PubMed ID: 30693788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.
    Mitchell A; Adams LA; MacQuillan G; Tibballs J; vanden Driesen R; Delriviere L
    Liver Transpl; 2008 Feb; 14(2):210-3. PubMed ID: 18236396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of effectiveness of coblation for recurrent epistaxis in hereditary hemorrhagic telangiectasia.
    Feller CN; Adams JA; Friedland DR; Poetker DM
    Am J Otolaryngol; 2022; 43(3):103409. PubMed ID: 35216850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
    Brinjikji W; Iyer VN; Wood CP; Lanzino G
    J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
    Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
    J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).
    Cottin V; Dupuis-Girod S; Lesca G; Cordier JF
    Respiration; 2007; 74(4):361-78. PubMed ID: 17641482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia.
    Kanellopoulou T; Alexopoulou A
    Expert Opin Biol Ther; 2013 Sep; 13(9):1315-23. PubMed ID: 23815519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of bevacizumab on familial epistaxis caused by hereditary hemorrhagic telangiectasia].
    Zhang J; Wang XS; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 May; 56(5):436-441. PubMed ID: 34010995
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research progress of bevacizumab in the treatment of refractory epistaxis caused by hereditary hemorrhagic telangiectasia].
    Xu C; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 51(6):476-9. PubMed ID: 27345893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does severe bleeding in HHT patients respond to intravenous bevacizumab? Review of the literature and case series.
    Rosenberg T; Fialla AD; Kjeldsen J; Kjeldsen AD
    Rhinology; 2019 Aug; 57(4):242-251. PubMed ID: 30907391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy.
    Galiatsatos P; Wilson C; O'Brien J; Gong AJ; Angiolillo D; Johnson J; Myers C; Strout S; Mathai S; Robinson G; Rowan NR; Weiss CR
    Orphanet J Rare Dis; 2022 Jun; 17(1):220. PubMed ID: 35698080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal bevacizumab injections improve quality of life in HHT patients.
    Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
    Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature.
    Arizmendez NP; Rudmik L; Poetker DM
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1042-7. PubMed ID: 26202958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab.
    Albitar HA; Almodallal Y; Nishimura R; Iyer VN
    Mayo Clin Proc Innov Qual Outcomes; 2020 Aug; 4(4):460-463. PubMed ID: 32793873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease.
    Ford TJ; Fong MW; Cheah BC; Alexopolous C
    J R Coll Physicians Edinb; 2014; 44(2):126-9. PubMed ID: 24999773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical Treatment vs Nonsurgical Treatment for Brain Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia: A Retrospective Multicenter Consortium Study.
    Meybodi AT; Kim H; Nelson J; Hetts SW; Krings T; terBrugge KG; Faughnan ME; Lawton MT;
    Neurosurgery; 2018 Jan; 82(1):35-47. PubMed ID: 28973426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future treatments for hereditary hemorrhagic telangiectasia.
    Robert F; Desroches-Castan A; Bailly S; Dupuis-Girod S; Feige JJ
    Orphanet J Rare Dis; 2020 Jan; 15(1):4. PubMed ID: 31910860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.